Reversible mitotic and metabolic inhibition following the encapsulation of fibroblasts in alginate hydrogels
- 1 November 2009
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 30 (32) , 6435-6443
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healingWound Repair and Regeneration, 2008
- Engineering tissues, organs and cellsJournal of Tissue Engineering and Regenerative Medicine, 2007
- Challenges in tissue engineeringJournal of The Royal Society Interface, 2006
- Mechanobiology in the Third DimensionAnnals of Biomedical Engineering, 2005
- Bioreactor-based engineering of osteochondral grafts: from model systems to tissue manufacturingJournal of Bioscience and Bioengineering, 2005
- Technology of mammalian cell encapsulationAdvanced Drug Delivery Reviews, 2000
- Tissue engineering using synthetic extracellular matricesNature Medicine, 1996
- Stability of hydrogels used in cell encapsulation: An in vitro comparison of alginate and agaroseBiotechnology and Bioengineering, 1996
- Microencapsulation of mammalian cells in a HEMA‐MMA copolymer: Effects on capsule morphology and permeabilityJournal of Biomedical Materials Research, 1990
- Microencapsulated Islets as Bioartificial Endocrine PancreasScience, 1980